Edition:
United States

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

5.50USD
15 Nov 2018
Change (% chg)

-- (--)
Prev Close
$5.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
129,246
52-wk High
$14.62
52-wk Low
$5.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 40.79 0.008
Jun '18 9.04 -0.078
Mar '18 8.20 -0.037
FY 2017 Dec '17 4.27 -0.049
Sep '17 27.18 -0.002
Jun '17 3.52 -0.036
Mar '17 2.86 -0.051
FY 2016 Dec '16 8.54 -0.036
Sep '16 2.42 -0.044
Jun '16 0.33 -0.052
Mar '16 2.92 -0.037
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 8 5.72 20.00 0.00 3.73
Quarter Ending Mar-19 4 2.25 4.00 0.00 --
Year Ending Dec-18 8 62.07 78.00 50.00 52.40
Year Ending Dec-19 8 22.25 65.00 0.00 16.42
Earnings (per share)
Quarter Ending Dec-18 6 -0.32 -0.23 -0.46 -0.30
Quarter Ending Mar-19 3 -0.32 -0.26 -0.36 --
Year Ending Dec-18 5 -0.95 -0.87 -1.09 -0.81
Year Ending Dec-19 6 -1.18 -0.94 -1.45 -1.46
LT Growth Rate (%) 1 1.00 1.00 1.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 80.78 29.53
P/E High - Last 5 Yrs. -- 271.55 46.39
P/E Low - Last 5 Yrs. -- 85.74 24.60
Beta 2.02 0.73 0.87
Price to Sales (TTM) 10.07 222.00 22.95
Price to Book (MRQ) 2.27 16.68 4.15
Price to Tangible Book (MRQ) 2.28 20.59 13.93
Price to Cash Flow (TTM) -- 49.18 20.94
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.41 1.64
Dividend Yield - 5 Year Avg -- 0.22 1.44
Dividend 5 Year Growth Rate -- 3.68 -6.04
Payout Ratio(TTM) -- 7.83 43.09

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 50.05 150.98 6.93
Sales (TTM) vs TTM 1 Yr. Ago 47.98 62.54 5.64
Sales - 5 Yr. Growth Rate -- 22.39 7.40
EPS (MRQ) vs Qtr. 1 Yr. Ago 640.38 81.55 31.31
EPS (TTM) vs TTM 1 Yr. Ago -23.60 -- --
EPS - 5 Yr. Growth Rate -- 20.67 7.72
Capital Spending - 5 Yr. Growth Rate -- 34.65 8.04

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.40 2.57
Current Ratio (MRQ) 8.85 6.54 3.54
LT Debt to Equity (MRQ) 0.00 18.54 11.13
Total Debt to Equity (MRQ) 0.00 24.12 15.47
Interest Coverage (TTM) -- -171.25 40.54

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 30.20 54.22
Gross Margin - 5 Yr. Avg. -- 47.69 52.88
EBITD Margin (TTM) -116.39 -- --
EBITD - 5 Yr. Avg -- -158.11 15.99
Operating Margin (TTM) -128.35 -1,802.66 -15.93
Operating Margin - 5 Yr. Avg. -- -171.35 11.25
Pre-Tax Margin (TTM) -138.71 -1,733.97 -14.34
Pre-Tax Margin - 5 Yr. Avg. -- -174.09 11.56
Net Profit Margin (TTM) -139.02 -1,729.63 -17.68
Net Profit Margin - 5 Yr. Avg. -- -174.34 7.82
Effective Tax Rate (TTM) -- 14.44 21.42
Effective Tax Rate - 5 Yr. Avg. -- 19.47 24.42

Efficiency

  Company industry sector
Revenue/Employee (TTM) 167,914 24,905,406 736,529,376
Net Income/Employee (TTM) -233,434 -3,414,886 85,218,449
Receivable Turnover (TTM) 20.45 8.44 5.31
Inventory Turnover (TTM) -- 2.76 4.11
Asset Turnover (TTM) 0.20 0.47 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -28.35 -0.62 10.32
Return on Assets - 5 Yr. Avg. -- 2.63 10.91
Return on Investment (TTM) -33.77 -0.25 13.00
Return on Investment - 5 Yr. Avg. -- 2.50 14.00
Return on Equity (TTM) -34.29 -3.01 14.69
Return on Equity - 5 Yr. Avg. -- -1.47 15.29
  1 Year 3 Year 5 Year
Sales % 166.47 -- --
EPS (TTM) % 21.12 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Adaptimmune Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -49.37 -47.74 4 91
13 Week -28.83 -25.75 55 95
26 Week -53.16 -53.35 33 91
52 Week -23.08 -26.96 89 98
YTD -10.18 -11.78 99 92
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 62.93%
# of Holders: 102
Total Shares Held: 65,808,242
3 Mo. Net Change: 9,517,172
# New Positions: 17
# Closed Positions: 14
# Increased Positions: 38
# Reduced Positions: 52
# Net Buyers: -14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.